ARTICLE | Clinical News
SecreFlo regulatory update
March 26, 2012 7:00 AM UTC
FDA's Gastrointestinal Drugs Advisory Committee will meet on May 31 to discuss an NDA from Repligen for SecreFlo to improve detection of pancreatic duct abnormalities in combination with MRI in patien...